|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||732.69 - 736.66|
|52-week range||732.69 - 736.66|
|Beta (5Y monthly)||0.17|
|PE ratio (TTM)||24.09|
|Earnings date||02 Feb 2023 - 06 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
In the last year, many Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) insiders sold a substantial stake in the company...
Regeneron (REGN) has had a good run in 2022 so far and the momentum should continue in 2023 as well.
Updates from CTMX and APLS are the key highlights from the biotech sector during the past week.